These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2162062

  • 1. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL, Dau PC, Khatri BO, Petajan J, Birnbaum G, McQuillen MP, Fosburg MT, Feldstein M, Orav J.
    Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
    [No Abstract] [Full Text] [Related]

  • 2. [Current therapy of multiple sclerosis. Are there indications for plasmapheresis?].
    Schönbeck S, Hohlfeld R.
    Nervenarzt; 1992 Feb; 63(2):116-9. PubMed ID: 1314334
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL, Dau PC, Khatri BO, Petajan JH, Birnbaum G, McQuillen MP, Fosburg MT, Feldstein M, Orav EJ.
    Neurology; 1989 Sep; 39(9):1143-9. PubMed ID: 2549450
    [Abstract] [Full Text] [Related]

  • 5. [Immunosuppressive treatment im multiple sclerosis].
    Mertin J.
    Fortschr Med; 1980 Oct 02; 98(37):1431-6. PubMed ID: 6253370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunosuppression in progressive multiple sclerosis with high dose intravenous cyclophosphamide and monoclonal antibodies.
    Dawson DM, Carter JL, Hafler DA, Weiner HL.
    Riv Neurol; 1987 Oct 02; 57(2):88-91. PubMed ID: 3039645
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Multiple sclerosis. II. A critical assessment of immunotherapy.
    Durelli L, Bergamini L.
    Riv Neurol; 1989 Oct 02; 59(5):191-201. PubMed ID: 2483962
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunosuppression with high-dose i.v. cyclophosphamide and ACTH in progressive multiple sclerosis: cumulative 6-year experience in 164 patients.
    Carter JL, Hafler DA, Dawson DM, Orav J, Weiner HL.
    Neurology; 1988 Jul 02; 38(7 Suppl 2):9-14. PubMed ID: 2838768
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [New therapeutic possibilities for disseminated sclerosis?].
    Wanscher B, Sørensen PS.
    Ugeskr Laeger; 1994 Oct 24; 156(43):6353-8. PubMed ID: 7810008
    [Abstract] [Full Text] [Related]

  • 15. [Current therapy of multiple sclerosis].
    Vass K, Schmied M.
    Wien Med Wochenschr; 1996 Oct 24; 146(19-20):514-9. PubMed ID: 9082651
    [Abstract] [Full Text] [Related]

  • 16. Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.
    Polman CH, Dahlke F, Thompson AJ, Ghazi M, Kappos L, Miltenburger C, Pozilli C.
    Mult Scler; 1995 Oct 24; 1 Suppl 1():S51-4. PubMed ID: 9345400
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of multiple sclerosis.
    McFarlin DE.
    N Engl J Med; 1983 Jan 27; 308(4):215-7. PubMed ID: 6294519
    [No Abstract] [Full Text] [Related]

  • 19. Current medical treatment of multiple sclerosis.
    Alter M.
    Clin Ther; 1983 Jan 27; 5(5):455-60. PubMed ID: 6193881
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.